Index of reports
> Cases with Refusal of Treatment by Patient (1)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Orap (Pimozide) where reactions include refusal of treatment by patient. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Orap side effects in 59 year old female
Reported by a consumer/non-health professional from United States on 2012-04-10
Patient: 59 year old female, weighing 98.4 kg (216.5 pounds)
Reactions: Anxiety, Refusal of Treatment by Patient, Fear, Condition Aggravated, Tourette's Disorder
Drug(s) suspected as cause:
Haldol
Dosage: 5 mg;qd;po
Administration route: Oral
Indication: Tourette's Disorder
Start date: 2012-03-28
Pimozide (NO Pref. Name)
Dosage: 4 mg;qd;po
Administration route: Oral
End date: 2012-03-01
Orap
Dosage: 2 mg;qd;po
Administration route: Oral
Indication: Tourette's Disorder
Start date: 1985-01-01
Orap
Dosage: 2 mg;qd;po
Administration route: Oral
Indication: Condition Aggravated
Start date: 1985-01-01
Benztropine Mesylate
Dosage: ;qd or bid;
Indication: Adverse Event
Start date: 2012-01-01
End date: 2012-01-01
|